Remove Article Remove Immune Response Remove Regulations
article thumbnail

Regulatory Guidance for Oligonucleotide Bioanalysis in Drug Development

Alta Sciences

Beyond bioanalysis, understanding the mechanism of action is equally important, as different classes of oligonucleotidessuch as antisense oligonucleotides (ASOs)interact with mRNA in distinct ways to regulate gene expression. These interactions may disrupt protein function, trigger immune responses, or contribute to other toxicological risks.

article thumbnail

Advancements in hit identification for membrane protein drug discovery

Drug Target Review

Involved in various physiological processes, such as vision, taste, smell, immune response and neurotransmission, GPCRs are activated by various molecules including hormones, neurotransmitters and environmental stimuli, which trigger a cascade of cellular events that help regulate bodily functions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The first major set of genetic associations found in long COVID

Drug Target Review

The genes unique to the severe long COVID patients were found to be associated with immune pathways such as myeloid differentiation, macrophage foam cells and lipid signalling pathways. The article mentions that TLR4 antagonists have been identified as potential candidates for repurposing long COVID treatment.

article thumbnail

Assessment of the anti?inflammatory mechanism of quercetin 3,7?dirhamnoside using an integrated pharmacology strategy

Chemical Biology and Drug Design

Through an assessment of pharmacology-based method, we found that QDR significantly inhibited lipopolysaccharides-induced inducible nitric oxide synthase expression, nitric oxide release and the generation of proinflammatory cytokines IL-6, IL-1β, and TNF-α by regulating the expression of AKT1, mTOR, and NOS to against inflammatory.

article thumbnail

Decoding stem cells for personalised regenerative medicine

Drug Target Review

In research published in Scientific Reports , 1 investigators focused on mesenchymal stem cells (MSCs), known for their potential in treating cell defects and regulating immune responses.

RNA 128
article thumbnail

The potential of CD24 in cancer immunotherapy

Drug Target Review

This interaction inhibits inflammation and immune activation, and in particular prevents macrophages from phagocytosing and destroying cancer cells. By blocking CD24 with an antibody drug, our goal is to powerfully reactivate the anti-cancer immune response and drive therapeutic efficacy.

article thumbnail

Laurie Glimcher

Broad Institute

A trailblazer in cancer research, Glimcher's research identified key transcriptional regulators of protective immunity and the origin of pathophysiologic immune responses underlying autoimmune, infectious, and malignant diseases.